S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

PBLA Panbela Therapeutics Inc

1.11

0.00 (0.00%)

28 Feb 2025 - Closed

Delayed by 15 minutes

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Article too big to display. Click here to view on the SEC website

Panbela Therapeutics (NASDAQ:PBLA)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Panbela Therapeutics Charts.

Panbela Therapeutics (NASDAQ:PBLA)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Panbela Therapeutics Charts.

Panbela Therapeutics Inc News

First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center
Tuesday 24 September 2024 (5 months ago) • GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Saturday 17 August 2024 (6 months ago) • Edgar (US Regulatory)

Panbela Provides Business Update and Reports Q2 2024 Financial Results
Wednesday 14 August 2024 (7 months ago) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Wednesday 31 July 2024 (7 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 31 July 2024 (7 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 4 July 2024 (8 months ago) • Edgar (US Regulatory)

Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification
Monday 24 June 2024 (8 months ago) • GlobeNewswire Inc.

Panbela Announces Oral Presentation at Digestive Disease Week (DDW):
Monday 10 June 2024 (9 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 29 May 2024 (9 months ago) • Edgar (US Regulatory)

Panbela Provides Business Update and Reports Q1 2024 Financial Results
Thursday 16 May 2024 (10 months ago) • GlobeNewswire Inc.

Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
Monday 6 May 2024 (10 months ago) • GlobeNewswire Inc.

Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
Thursday 2 May 2024 (10 months ago) • GlobeNewswire Inc.

More Panbela Therapeutics Inc News Articles

Woodside Petroleum

National Australia Bank

Newcrest Mining

Australian SE All Ordina...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions